Cue Biopharma Inc buy Piper Sandler
Start price
06.11.23
/
50%
€2.38
Target price
06.11.24
€7.45
Performance (%)
-29.95%
End price
07.11.24
€1.67
Summary
This prediction ended on 07.11.24 with a price of €1.67. The price of Cue Biopharma Inc has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -29.95%. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Cue Biopharma Inc | -18.995% | -18.995% | -78.497% |
| iShares Core DAX® | 1.604% | -7.448% | 3.039% |
| iShares Nasdaq 100 | -0.734% | -1.864% | 15.425% |
| iShares Nikkei 225® | 1.296% | -6.795% | 34.306% |
| iShares S&P 500 | -0.394% | -2.336% | 9.907% |
Comments by Piper_Sandler for this prediction
In the thread Cue Biopharma Inc diskutieren
Cue Biopharma, Inc. (NASDAQ: CUE) had its price target raised by analysts at Piper Sandler from $7.00 to $8.00. They now have an "overweight" rating on the stock.
Ratings data for CUE provided by MarketBeat
In the thread Trading Cue Biopharma Inc
Die von Piper_Sandler gewählte maximale Laufzeit wurde überschritten